Ligand Pharmaceuticals (LGND) Net Margin (2010 - 2026)
Ligand Pharmaceuticals (LGND) reported Net Margin of 25.8% for Q1 2026, up 6784.0% on a YoY basis from 0.37% in Q1 2025, and down 134.38% sequentially from 75.06% in Q4 2025.
Ligand Pharmaceuticals (LGND) Net Margin (2010 - 2026) Analysis & Trends
Ligand Pharmaceuticals (LGND) has 15 years of Net Margin data on file, last reported at 25.8% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 6784.0% year-over-year to 25.8%; the trailing twelve-month figure through Mar 2026 stood at 55.95% (up 9647.0% YoY), and the FY2025 full-year result was 46.42%, up 4884.0% from the prior year.
- Net Margin declined to 25.8% in Q1 2026, from 75.06% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 101.57% in Q3 2025 to a low of 93.64% in Q1 2025.
- A 5-year average of 5.83% and a median of 6.73% in 2022 frame the typical range for Net Margin.
- Across the five-year window, Net Margin sank 1967 bps in 2022 and soared 14767 bps in 2025, its largest moves.
- Tracing LGND's Net Margin over 5 years: stood at 5.86% in 2022, then soared by 35 bps to 3.79% in 2023, then plunged by 1818 bps to 72.62% in 2024, then soared by 203 bps to 75.06% in 2025, then slumped by 134 bps to 25.8% in 2026.
- Business Quant data shows LGND's Net Margin at 25.8% in Q1 2026, 75.06% in Q4 2025, and 101.57% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ligand Pharmaceuticals | 6.05 Bn | 5.27 Bn | 48.45 Mn | -25.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.80% |
| Dec 31, 2025 | 75.06% |
| Sep 30, 2025 | 101.57% |
| Jun 30, 2025 | 10.18% |
| Mar 31, 2025 | -93.64% |
| Dec 31, 2024 | -72.62% |
| Mar 31, 2023 | -3.79% |
| Dec 31, 2022 | -5.86% |
| Sep 30, 2022 | -15.60% |
| Jun 30, 2022 | -26.92% |
| Mar 31, 2022 | -6.73% |
| Dec 31, 2021 | -3.94% |
| Sep 30, 2021 | -11.08% |
| Jun 30, 2021 | -7.25% |
| Mar 31, 2021 | -10.00% |
| Dec 31, 2020 | 25.13% |
| Sep 30, 2020 | -16.01% |
| Jun 30, 2020 | 53.32% |
| Mar 31, 2020 | -72.77% |
| Dec 31, 2019 | -27.27% |